REGENXBIO
0 followers
RGNX
Performance
About REGENXBIO
REGENXBIO is a leading clinical-stage biotechnology company focused on gene therapy. The company develops therapies using its NAV® Technology Platform to deliver one-time treatments for retinal, metabolic, and neurodegenerative diseases, aiming to improve lives for patients. Based in the United States, it emphasizes advancing novel AAV-based gene therapies through steady clinical programs and partnerships.
Recent News
Recent Deals
No recent deals for this company.